Literature DB >> 33823121

Quantitative characterization of the T cell receptor repertoires of human immunized by rabies virus vaccine.

Pingsen Zhao1,2,3, Kaijian Hou4, Zhixiong Zhong5, Sharula Guo6, Songtao Yang7, Xianzhu Xia3,7.   

Abstract

Cellular immunity is crucial for an efficient host immune response against rabies virus (RABV) infection. But the T cell receptor (TCR) repertoire in human after RABV vaccine immunization remained unclear. In this study, we conducted high-throughput sequencing of TCR β chain complementarity determining region 3(CDR3) repertoires in 4 healthy volunteers before and after immunization with RABV vaccine. Our data showed that RABV vaccination changed the TCR diversity and the usage of V/J gene segments, as well as V-J pairing. The high-frequency clonotypes that altered after vaccination were identified. These results may provide us with new insights into T cell receptor condition after RABV vaccination.

Entities:  

Keywords:  Rabies virus (RABV); T cell receptor (TCR) repertoire; complementarity determining region 3(CDR3); high-throughput sequencing; immune response

Mesh:

Substances:

Year:  2021        PMID: 33823121      PMCID: PMC8475554          DOI: 10.1080/21645515.2021.1893575

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  31 in total

1.  Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4).

Authors:  E Celis; J Larson; L Otvos; W H Wunner
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

2.  Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma.

Authors:  E Celis; R W Miller; T J Wiktor; B Dietzschold; H Koprowski
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  MiXCR: software for comprehensive adaptive immunity profiling.

Authors:  Dmitriy A Bolotin; Stanislav Poslavsky; Igor Mitrophanov; Mikhail Shugay; Ilgar Z Mamedov; Ekaterina V Putintseva; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2015-05       Impact factor: 28.547

Review 4.  The molecular biology of rabies viruses.

Authors:  W H Wunner; J K Larson; B Dietzschold; C L Smith
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

5.  Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes.

Authors:  René L Warren; J Douglas Freeman; Thomas Zeng; Gina Choe; Sarah Munro; Richard Moore; John R Webb; Robert A Holt
Journal:  Genome Res       Date:  2011-02-24       Impact factor: 9.043

6.  Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer.

Authors:  Qingzhu Jia; Junfeng Zhou; Gang Chen; Yan Shi; Haili Yu; Peng Guan; Regina Lin; Ning Jiang; Peiwu Yu; Qi-Jing Li; Ying Wan
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 7.  Rabies re-examined.

Authors:  Charles E Rupprecht; Cathleen A Hanlon; Thiravat Hemachudha
Journal:  Lancet Infect Dis       Date:  2002-06       Impact factor: 25.071

8.  Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

9.  Systematic Comparative Evaluation of Methods for Investigating the TCRβ Repertoire.

Authors:  Xiao Liu; Wei Zhang; Xiaojing Zeng; Ruifang Zhang; Yuanping Du; Xueyu Hong; Hongzhi Cao; Zheng Su; Changxi Wang; Jinghua Wu; Chao Nie; Xun Xu; Karsten Kristiansen
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

Review 10.  A Systematic Review of Human Bat Rabies Virus Variant Cases: Evaluating Unprotected Physical Contact with Claws and Teeth in Support of Accurate Risk Assessments.

Authors:  Virginia M Dato; Enzo R Campagnolo; Jonah Long; Charles E Rupprecht
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.